about
An overview of Cdk1-controlled targets and processesA scalable method for molecular network reconstruction identifies properties of targets and mutations in acute myeloid leukemiaCdk6-dependent regulation of G(1) length controls adult neurogenesisPhosphorylation of p27Kip1 by JAK2 directly links cytokine receptor signaling to cell cycle controlDDX3 regulates cell growth through translational control of cyclin E1Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2Checkpoint recovery in cells: how a molecular understanding can help in the fight against cancerInterplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma proteinKnockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machineryCyclin-dependent kinase inhibitor therapy for hematologic malignanciesSkp2: a novel potential therapeutic target for prostate cancerMolecular mechanisms involved in farnesol-induced apoptosisCiliogenesis and the DNA damage response: a stressful relationshipRationale and Methodology of Reprogramming for Generation of Induced Pluripotent Stem Cells and Induced Neural Progenitor CellsNovel Molecular Markers for Breast CancerInfected cell protein 0 functional domains and their coordination in herpes simplex virus replicationThe Role of Cdkn1A-Interacting Zinc Finger Protein 1 (CIZ1) in DNA Replication and PathophysiologyChemoprevention of Breast Cancer by Dietary PolyphenolsTargeted Therapies in Adult B-Cell MalignanciesTargeting the Checkpoint to Kill Cancer CellsTargeting CDK6 in cancer: State of the art and new insightsMYC and the art of microRNA maintenanceTargeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitorsTen things you should know about protein kinases: IUPHAR Review 14NIRF/UHRF2 occupies a central position in the cell cycle network and allows coupling with the epigenetic landscapePhosphoregulation of the WAVE regulatory complex and signal integrationOptimizing treatments for lymphangioleiomyomatosisTwo-way communication between the metabolic and cell cycle machineries: the molecular basisMitotic and mitogenic Wnt signallingFluorescent peptide biosensor for probing the relative abundance of cyclin-dependent kinases in living cellsGrowth inhibition of head and neck squamous cell carcinoma cells by sgRNA targeting the cyclin D1 mRNA based on TRUE gene silencingBriefly Bound to Activate: Transient Binding of a Second Catalytic Magnesium Activates the Structure and Dynamics of CDK2 Kinase for CatalysisCDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma CellsPrice To Be Paid for Two-Metal Catalysis: Magnesium Ions That Accelerate Chemistry Unavoidably Limit Product Release from a Protein KinaseSubstituted 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidines Are Highly Active CDK9 Inhibitors: Synthesis, X-ray Crystal Structures, Structure–Activity Relationship, and Anticancer ActivitiesFragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 InhibitorsCoordinating cell polarity and cell cycle progression: what can we learn from flies and worms?D-type Cyclins are important downstream effectors of cytokine signaling that regulate the proliferation of normal and neoplastic mammary epithelial cells.Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts.Identification of YPL014W (Cip1) as a novel negative regulator of cyclin-dependent kinase in Saccharomyces cerevisiae.
P2860
Q21203553-F0502CBE-01FF-4F80-B7F2-E9B5926FDCA0Q24289222-0554D7E5-3A89-4013-B462-B1A316D9F9D7Q24293050-462041F4-AF6D-4DE0-8AC0-F9D8B7345703Q24297854-F0CD6B73-9609-40C3-8323-F4C92F65D77CQ24299653-C40CAEA2-D10C-48C0-AB44-1859061B2FF0Q24302263-96F470BA-25C2-443A-83AF-14B28EAC8961Q24306163-7925726F-CCAA-4991-AD14-5994F008C870Q24310370-A2207A7A-E43B-4AE5-9DCF-39A7E14C3964Q24336886-8C2BD361-DD27-41C5-9A1A-F9E1422ECCBDQ24561485-59713576-AF24-4B11-93E2-AFBDAC566EAAQ24625558-26EC78AF-B6F7-4E8B-880C-378F428ACC14Q24655100-086EC250-5505-42EB-BA20-8CAB4B003FE6Q26747601-FCEB01C8-4721-48F4-B560-395BE1015F3FQ26750951-6828F1E4-4204-40F5-9A2F-FC81B3B06480Q26753160-6BA40835-97CC-49A8-885E-18255BBC0CF2Q26766356-7A6FA4DD-6C6B-424F-964A-4C6E95074B9DQ26767281-AEF193F5-FB65-47F0-A76D-41FD206E42B0Q26773449-4F8B4064-89C6-4B27-B87A-149388D73DA1Q26783195-7BFBEAB7-8932-4B86-9D95-19DF4D57B1EEQ26795781-63D7215A-EB63-4CF1-8EE3-8CEB19F40058Q26796499-F6B0CA33-5929-45A0-B6BF-14D38134389FQ26825457-C1C41270-B6C6-429C-A593-7A1CDAB60E75Q26827580-5C1D62C9-D992-46FD-BB54-FAC4EF47E9FBQ26849417-73D8339D-2001-43CF-BE0C-DC11443D155FQ26851503-F0CF0542-966B-4B35-A4CF-AE0E238D928DQ26863403-800673C8-B853-49DD-B340-8923315E8983Q26865250-E61672F5-2668-42EE-A29E-28E5643E704EQ27013594-8932647B-FC59-4F3A-8C6E-BBA89F396299Q27021818-4A9DF3F3-E4A3-4AC8-B9EA-B9EED605A6EEQ27315827-417E9ECD-3FDC-4C4A-A907-1762286ABCA1Q27322637-9F2835D7-C591-416E-B2C1-5D9000F8DA77Q27667818-EA8C9A0B-C59F-4521-A28C-03517AA94697Q27670943-9C4135FB-E49B-4827-9079-F7B4389B70D1Q27671541-E3375877-1BF1-400E-9AB6-8774B27EBE44Q27675842-03582917-70E1-4CCB-9F7B-577F287088CAQ27684150-410953E8-6979-4F51-AC49-C72AA30D91B2Q27687672-3A20C639-68A4-4715-BE3B-88F9C988892AQ27690967-D08344BF-3BD8-4675-9DB3-7A0017FED8A5Q27851556-BD0B6CF2-3DFC-44DD-8746-38D344C8BD0BQ27936771-82DB39F0-53A1-40D2-A91B-B080E8CEF0CD
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cell cycle, CDKs and cancer: a changing paradigm
@ast
Cell cycle, CDKs and cancer: a changing paradigm
@en
Cell cycle, CDKs and cancer: a changing paradigm
@en-gb
Cell cycle, CDKs and cancer: a changing paradigm
@nl
type
label
Cell cycle, CDKs and cancer: a changing paradigm
@ast
Cell cycle, CDKs and cancer: a changing paradigm
@en
Cell cycle, CDKs and cancer: a changing paradigm
@en-gb
Cell cycle, CDKs and cancer: a changing paradigm
@nl
prefLabel
Cell cycle, CDKs and cancer: a changing paradigm
@ast
Cell cycle, CDKs and cancer: a changing paradigm
@en
Cell cycle, CDKs and cancer: a changing paradigm
@en-gb
Cell cycle, CDKs and cancer: a changing paradigm
@nl
P3181
P356
P1476
Cell cycle, CDKs and cancer: a changing paradigm
@en
P2888
P304
P3181
P356
10.1038/NRC2602
P407
P577
2009-03-01T00:00:00Z
P5875
P6179
1008867916